Hyalocytes: Essential vitreous cells in vitreoretinal health and disease

Takeshi Kita, Taiji Sakamoto, Tatsuro Ishibashi

Research output: Chapter in Book/Report/Conference proceedingChapter

9 Citations (Scopus)

Abstract

Vitreoretinal interface diseases are common causes of vision loss or metamorphopsia in spite of recent advances in clinical ophthalmology including vitreoretinal surgery, pharmacological therapy such as anti-VEGF agents, and gene-mediated therapy. The vitreous is often used as a therapeutic place or platform for these therapies; therefore, more detailed knowledge about the environment of the vitreous is required.

Original languageEnglish
Title of host publicationVitreous
Subtitle of host publicationIn Health and Disease
PublisherSpringer New York
Pages151-164
Number of pages14
ISBN (Electronic)9781493910861
ISBN (Print)9781493910854
DOIs
Publication statusPublished - Jan 1 2014
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Fingerprint Dive into the research topics of 'Hyalocytes: Essential vitreous cells in vitreoretinal health and disease'. Together they form a unique fingerprint.

Cite this